Pfizer Current Ratio 2006-2019 | PFE

Current and historical current ratio for Pfizer (PFE) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Pfizer current ratio for the three months ending December 31, 2019 was .
Pfizer Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $0.00B 0.00
2019-09-30 $33.46B $36.97B 0.91
2019-06-30 $47.07B $32.03B 1.47
2019-03-31 $45.29B $29.42B 1.54
2018-12-31 $49.93B $31.86B 1.57
2018-09-30 $41.58B $29.01B 1.43
2018-06-30 $37.30B $32.16B 1.16
2018-03-31 $34.84B $27.37B 1.27
2017-12-31 $41.14B $30.43B 1.35
2017-09-30 $40.29B $28.22B 1.43
2017-06-30 $36.39B $27.18B 1.34
2017-03-31 $35.88B $24.86B 1.44
2016-12-31 $38.95B $31.12B 1.25
2016-09-30 $38.50B $34.76B 1.11
2016-06-30 $43.85B $32.10B 1.37
2016-03-31 $41.30B $28.74B 1.44
2015-12-31 $43.80B $29.40B 1.49
2015-09-30 $45.00B $27.85B 1.62
2015-06-30 $51.72B $24.14B 2.14
2015-03-31 $49.44B $20.22B 2.45
2014-12-31 $55.60B $21.59B 2.58
2014-09-30 $56.99B $19.92B 2.86
2014-06-30 $58.29B $21.94B 2.66
2014-03-31 $57.79B $24.79B 2.33
2013-12-31 $56.24B $23.37B 2.41
2013-09-30 $59.50B $20.37B 2.92
2013-06-30 $61.44B $23.45B 2.62
2013-03-31 $64.76B $27.54B 2.35
2012-12-31 $64.83B $29.19B 2.22
2012-09-30 $57.13B $29.13B 1.96
2012-06-30 $58.77B $30.80B 1.91
2012-03-31 $54.86B $27.09B 2.03
2011-12-31 $60.82B $28.91B 2.10
2011-09-30 $62.73B $27.86B 2.25
2011-06-30 $60.48B $30.47B 1.99
2011-03-31 $58.24B $29.17B 2.00
2010-12-31 $61.01B $28.64B 2.13
2010-09-30 $54.09B $24.17B 2.24
2010-06-30 $51.10B $24.68B 2.07
2010-03-31 $49.92B $25.92B 1.93
2009-12-31 $61.67B $37.23B 1.66
2009-09-30 $73.78B $23.99B 3.08
2009-06-30 $71.55B $26.11B 2.74
2009-03-31 $54.25B $23.34B 2.32
2008-12-31 $43.08B $27.01B 1.60
2008-09-30 $48.23B $21.50B 2.24
2008-06-30 $48.65B $23.19B 2.10
2008-03-31 $51.01B $21.68B 2.35
2007-12-31 $46.85B $21.84B 2.15
2007-09-30 $41.84B $14.33B 2.92
2007-06-30 $41.62B $15.14B 2.75
2007-03-31 $42.34B $13.30B 3.18
2006-12-31 $47.66B $22.10B 2.16
2006-09-30 $38.72B $17.69B 2.19
2006-06-30 $40.99B $20.06B 2.04
2006-03-31 $37.42B $19.67B 1.90
2005-12-31 $46.84B $28.40B 1.65
2005-09-30 $32.77B $20.40B 1.61
2005-06-30 $33.57B $22.57B 1.49
2005-03-31 $42.35B $28.95B 1.46
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $188.714B $51.750B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $366.542B 16.03
Roche Holding AG (RHHBY) Switzerland $279.316B 0.00
Merck (MRK) United States $198.032B 15.04
Novartis AG (NVS) Switzerland $197.141B 16.42
Novo Nordisk (NVO) Denmark $140.872B 24.18
AbbVie (ABBV) United States $126.350B 9.55
Eli Lilly (LLY) United States $123.555B 21.39
Sanofi (SNY) France $120.599B 14.33
AstraZeneca (AZN) United Kingdom $118.253B 25.46
GlaxoSmithKline (GSK) United Kingdom $103.779B 13.16
Bristol-Myers Squibb (BMY) United States $97.073B 12.76
Bayer (BAYRY) Germany $67.330B 9.70
H Lundbeck (HLUYY) Denmark $6.839B 11.88